治疗性细菌性角膜炎的视力恢复。
Visual recovery in treated bacterial keratitis.
机构信息
Department of Cornea and External Diseases, Aravind Eye Care System, Madurai, India.
Department of Cornea and External Diseases, Aravind Eye Care System, Coimbatore, India.
出版信息
Ophthalmology. 2014 Jun;121(6):1310-1. doi: 10.1016/j.ophtha.2013.12.041. Epub 2014 Mar 5.
Abstract
Bacterial keratitis is a leading cause of visual impairment worldwide. However, the natural history of treated bacterial keratitis has not been well characterized. We performed a secondary analysis of the Steroids for Corneal Ulcers Trial (SCUT; clinicaltrials.gov #NCT00324168) to better characterize the rate of visual acuity improvement after successful antimicrobial treatment.
摘要
细菌性角膜炎是全球导致视力损害的主要原因。然而，治疗后的细菌性角膜炎的自然病程尚未得到很好的描述。我们对皮质类固醇治疗角膜溃疡试验（SCUT；clinicaltrials.gov #NCT00324168）进行了二次分析，以更好地描述成功抗菌治疗后视力提高的速度。
相似文献
1
Visual recovery in treated bacterial keratitis.治疗性细菌性角膜炎的视力恢复。
Ophthalmology. 2014 Jun;121(6):1310-1. doi: 10.1016/j.ophtha.2013.12.041. Epub 2014 Mar 5.
2
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.治疗性细菌性角膜炎的视觉预后：四年前瞻性随访
Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2935-40. doi: 10.1167/iovs.14-13980.
3
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.绿脓杆菌角膜炎：结局和皮质类固醇治疗反应。
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840.
4
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.类固醇治疗角膜溃疡试验（SCUT）：一项随机对照试验的次要 12 个月临床结局。
Am J Ophthalmol. 2014 Feb;157(2):327-333.e3. doi: 10.1016/j.ajo.2013.09.025. Epub 2013 Oct 1.
5
Nocardia keratitis: clinical course and effect of corticosteroids.诺卡氏角膜炎：临床病程和皮质类固醇的作用。
Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5.
6
The steroids for corneal ulcers trial: study design and baseline characteristics.角膜溃疡类固醇试验：研究设计与基线特征
Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10.
7
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).用于细菌性角膜炎的皮质类固醇：角膜溃疡类固醇试验（SCUT）。
Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10.
8
Improvement in corneal scarring following bacterial keratitis.细菌性角膜炎后角膜瘢痕的改善。
Eye (Lond). 2013 Mar;27(3):443-6. doi: 10.1038/eye.2012.270. Epub 2012 Dec 14.
9
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.氟喹诺酮类药物治疗与细菌性角膜炎分离株的敏感性。
JAMA Ophthalmol. 2013 Mar;131(3):310-3. doi: 10.1001/jamaophthalmol.2013.1718.
10
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.印度南部铜绿假单胞菌角膜炎分离株中莫西沙星耐药性的出现。
Ophthalmic Epidemiol. 2013 Jun;20(3):155-8. doi: 10.3109/09286586.2013.790978. Epub 2013 May 10.
引用本文的文献
1
Factors Associated with Vision Outcomes in Microbial Keratitis: A Multisite Prospective Cohort Study.微生物性角膜炎视力预后的相关因素：一项多中心前瞻性队列研究。
Ophthalmology. 2025 Jul;132(7):830-841. doi: 10.1016/j.ophtha.2025.02.004. Epub 2025 Feb 8.
2
Infectious Keratitis in Patients Over 65: A Review on Treatment and Preserving Eyesight.老年患者感染性角膜炎：治疗和保视力的综述。
Clin Interv Aging. 2024 Jul 31;19:1393-1405. doi: 10.2147/CIA.S467262. eCollection 2024.
3
Epidemiological profile of microbial keratitis in Alexandria-Egypt a 5 years retrospective study.埃及亚历山大市微生物性角膜炎的流行病学概况：一项5年回顾性研究
J Ophthalmic Inflamm Infect. 2023 Apr 13;13(1):18. doi: 10.1186/s12348-023-00332-7.
4
Deterioration of wound healing and intense suppression of MMP-9 mRNA expression after short-term administration of different topical glucocorticoids or NSAIDs in an avian model of corneal lesions.在鸟类角膜损伤模型中，短期给予不同局部糖皮质激素或非甾体抗炎药后，伤口愈合恶化，基质金属蛋白酶-9（MMP-9）mRNA表达受到强烈抑制。
Iran J Vet Res. 2021 Summer;22(3):188-194. doi: 10.22099/ijvr.2021.39864.5783.
5
Urgent unmet needs in the care of bacterial keratitis: An evidence-based synthesis.急需满足细菌性角膜炎护理中的未满足需求：基于证据的综合分析。
Ocul Surf. 2023 Apr;28:378-400. doi: 10.1016/j.jtos.2021.08.013. Epub 2021 Aug 28.
6
Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment.抗微生物治疗成功 4 年后真菌性与细菌性角膜溃疡的视力损害。
Am J Ophthalmol. 2019 Aug;204:124-129. doi: 10.1016/j.ajo.2019.03.010. Epub 2019 Mar 20.
7
Novel Image-Based Analysis for Reduction of Clinician-Dependent Variability in Measurement of the Corneal Ulcer Size.基于图像的新型分析方法可减少角膜溃疡大小测量中依赖临床医生的变异性。
Cornea. 2018 Mar;37(3):331-339. doi: 10.1097/ICO.0000000000001488.
8
Role of steroids in the treatment of bacterial keratitis.类固醇在细菌性角膜炎治疗中的作用。
Clin Ophthalmol. 2016 Jan 27;10:179-86. doi: 10.2147/OPTH.S80411. eCollection 2016.
9
Pattern recognition receptors in microbial keratitis.微生物性角膜炎中的模式识别受体
Eye (Lond). 2015 Nov;29(11):1399-415. doi: 10.1038/eye.2015.118. Epub 2015 Jul 10.
10
Topical corticosteroids as adjunctive therapy for bacterial keratitis.局部用皮质类固醇作为细菌性角膜炎的辅助治疗
Cochrane Database Syst Rev. 2014 Oct 16;10(10):CD005430. doi: 10.1002/14651858.CD005430.pub3.
本文引用的文献
1
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.类固醇治疗角膜溃疡试验（SCUT）：一项随机对照试验的次要 12 个月临床结局。
Am J Ophthalmol. 2014 Feb;157(2):327-333.e3. doi: 10.1016/j.ajo.2013.09.025. Epub 2013 Oct 1.
2
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).用于细菌性角膜炎的皮质类固醇：角膜溃疡类固醇试验（SCUT）。
Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10.
3
The steroids for corneal ulcers trial: study design and baseline characteristics.角膜溃疡类固醇试验：研究设计与基线特征
Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10.
4
Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial.抗生素单一治疗与抗生素-皮质类固醇联合治疗角膜溃疡患者的比较：双盲随机临床试验。
Can J Ophthalmol. 2011 Feb;46(1):40-5. doi: 10.3129/i10-054.
5
A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal.一项关于聚维酮碘预防尼泊尔农村地区角膜溃疡所致视力损害的随机试验。
Br J Ophthalmol. 2004 Dec;88(12):1487-92. doi: 10.1136/bjo.2004.044412.
Zotero 插件